Pharmaceuticals
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board
2020-06-11 18:00
4770
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I
DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer. Under this agreement, PharmA...
2020-06-11 00:00
966
Menarini Group Completes a Solid Year of Operating Performance
- Turnover reaches €3,793 million, with an increase of 3.2% compared to 2018 and EBITDA of €492 million thanks to continued strong performance of its most important products - €150 million investment into new plant in Italy significantly increasing oral blister capacity in line with increased de...
2020-06-10 23:42
3307
Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
Joint Press Release * Covid-19 poses major challenges for developing and mass-producing vaccines and medicines in existing production facilities * Siemens and Exyte combine their strengths to offer intelligent, modular, and scalable biotech facilities * Siemens provides solutions for proces...
2020-06-10 08:45
4284
Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody
SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur ofShanghai, Chinese Academy of...
2020-06-10 08:40
5980
L.E.A.F. Pharmaceuticals Lead Investigational Product for Lung and Colorectal Cancers, LEAF-1401, Featured at the 2020 Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO)
Treatment with LEAF-1401 exposes the tumor to 20-times more pentaglutamated pemetrexed than conventional pemetrexed. Polyglutamated pemetrexed has been shown to be 80-times more potent than pemetrexed in inhibiting thymidylate synthase (TS), a key enzyme in the folate pathway. Pemetrexed (Alimta®...
2020-06-10 03:15
1693
Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry
The Frost Radar benchmarks the top 16 companies in the market excelling at growth and innovation SANTA CLARA, California, June 10, 2020 /PRNewswire/ -- Frost & Sullivan's Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry Radar has identified that organizations' need to mi...
2020-06-10 00:41
1127
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer
SUZHOU, China, June 8, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi (EURONEXT: SAN and NASDAQ: SNY), a global biopharmaceutical leader, announced today that Jiangsu Alpham...
2020-06-09 10:10
5878
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
CRANBURY, NJ and SHANGHAI, June 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has signed a 10-year lease for a clinical manufacturing facility (MFG18) inCranbury, New Jersey. The new clin...
2020-06-09 08:00
2305
Healios Successfully Establishes Proprietary Universal Donor Cell Research Line
TOKYO, June 5, 2020 /PRNewswire/ -- Healios K.K. (hereinafter "the Company"; TSE: 4593),Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (UDCs), which are next-generation iPS cells created with gene-editing technology to engineer a low risk of immune r...
2020-06-05 13:00
2205
Update: Deadline To File Claims Against Purdue Pharma L.P. Has Been Extended To July 30, 2020
NEW YORK, June 5, 2020 /PRNewswire/ -- The following is being issued by Prime Clerk LLC. In light of the ongoing COVID-19 pandemic, the U.S. Bankruptcy Court for the Southern District ofNew York has granted a 30-day extension of the deadline to file a claim against Purdue Pharma L.P.,1 including...
2020-06-05 01:19
2933
IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant
PRINCETON JUNCTION, New Jersey, June 4, 2020 /PRNewswire/ -- International Process Plants (IPP), a global buyer and seller of pharmaceutical and biopharmaceutical manufacturing facilities and equipment, announced its client AGC Biologics' successful Q2/20 purchase of a state-of-the-art commercial...
2020-06-04 21:34
3082
Servier Completes the Acquisition of Symphogen
PARIS, June 4, 2020 /PRNewswire/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S. Symphogen will now function as Servier's antibody center of excellence across multiple therapeutic areas, including oncology. ...
2020-06-04 21:30
2738
Press Launch of hVIVO COVID Clear Test, the Most Accurate Antibody Test Available to UK Employers to Help Get People Back to Work
Thursday 4 June 2020, 11am at hVIVO's world leading virology clinic in Whitechapel,East London We are making available for the first time on demand antibody testing direct to large employer groups in the UK We are also seeking channel partners to make testing available through GP networks, nurs...
2020-06-04 14:00
3595
China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering
HANGZHOU, China, June 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it clos...
2020-06-04 04:00
12382
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma
SYDNEY, June 3, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to67Cu-SARTATE™, a therapy for th...
2020-06-03 21:08
1396
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
AGC Biologics partners with Novavax to produce NVX-CoV2373 component SEATTLE, June 3, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner withNovavax, Inc. (NASDAQ: NVAX), a late-stage biot...
2020-06-03 19:00
3303
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
Key Highlights * TGA has granted provisional designation for new drug Lurbinectedin based on encouraging Phase 2 results and high unmet medical need * A marketing application has now been accepted by the TGA under provisional evaluation pathway * Lurbinectedin has received priority review u...
2020-06-03 14:30
1492
Toni Nesci Named Head of Mayne Contract Services and New Website Launched
ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury,South Australia is the full-service pharmaceutical development and manufacturing business unit create...
2020-06-03 10:39
2514
Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment
FREIBURG, Germany, June 3, 2020 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the co...
2020-06-03 10:00
1722
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 337 media titles]
2025-01-18 03:30
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 311 media titles]
2025-01-18 17:00
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 309 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
12394
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
11600
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
10232
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
10091